Science & Technology: Pharmacogenomics and Pharmaceutical Development: Current Thinking and Regulatory Guidance

Posted 01 March 2008 | By

Will pharmacogenomics truly become part of a much larger paradigm of personalized medicine, predicting the best possible treatment option in a regulatory framework designed to pick up adverse reactions much earlier in the pharmaceutical lifecycle?


Regulatory Focus newsletters

All the biggest regulatory news and happenings.